Redefine what’s possible in life sciences
In the era of intelligent technologies, organizations must reinvent to bring breakthrough treatments to patients, faster and at lower costs.
Life sciences now
100%
of Biopharma executives agree AI foundation models will enable connections across data types, revolutionizing where and how AI is used
92%
of Biopharma executives agree that technology plays a critical role in all current and future reinvention strategy
90%
of biopharma executives agree that data transparency is becoming a competitive differentiator
78%
New Sciences, the best in science and health technology is expected to drive 78% of revenue growth in the next five years
60%
of life sciences supply chain executives want better real-time inventory and visibility from external manufacturing partners
>50
Today, more than 50 drugs discovered through AI are progressing through clinical pipelines
How to reinvent life sciences
Accelerate innovation, drive productivity, and transform patient outcomes
Fulfill unmet patient needs with innovative and effective treatments
Cultivate new ways of working, innovating, collaborating and operating
Build a resilient supply chain to deliver high quality therapies and devices
Shift towards smart technology-centric products and redefine how data is utilized to improve patient care
Run your business with compliant, patient-centric, intelligent operations
Reinvent commercial models to better meet patients’ and HCPs’ needs
What’s trending in life sciences
Awards and recognition
Market Leader in Horizon 3 Life Sciences Service Providers Report
Position #1: Life Sciences Smart Manufacturing Services Lead
Our life sciences leaders
Petra Jantzer, Ph.D.
Senior Managing Director – Global Life Sciences Lead
Ramon Pressburger
Managing Director – North America Lead and Strategy Lead, Global Life Sciences
Jan Ising
Managing Director – Europe, Global Life Sciences
Daishi Miyao
Managing Director – Growth Markets, Global Life Sciences